AlzeCure Pharma AB (publ)

SSE:ALZCUR.ST

2.49 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Omzet 0000000000000000000000001.1091.1360.8830
Kosten van de omzet 0.0690.1090.110.1090.1250.1320.1360.1450.1450.1440.1450.1460.1610.124019.65316.00411.35413.63712.1899.1679.79505.7397.9210.12700
Brutowinst -0.069-0.109-0.11-0.109-0.125-0.132-0.136-0.145-0.145-0.144-0.145-0.146-0.161-0.1240-19.653-16.004-11.354-13.637-12.189-9.167-9.7950-5.739-6.811-8.9910.8830
Brutowinstmarge 000000000000000000000000-6.142-7.91510
Onderzoek- en ontwikkelingskosten 5.7887.0126.9465.6287.8987.1258.1998.93418.88810.16219.67414.17413.33419.53315.31519.65316.00411.35413.63712.1899.1679.79513.1465.7397.9210.1276.2050
Algemene en administratieve kosten 2.9972.9352.9832.3342.5792.7022.8342.1912.6182.5252.8932.372.6213.3812.4981.882.5872.3882.0541.1561.1291.69730.7530.4560.7150.5710.4020.328
Verkoop- en marketingkosten 000000000000000000000000004.7684.675
Verkoop-, algemene en administratieve kosten 2.9972.9352.9832.3342.5792.7022.8342.1912.6182.5252.8932.372.6213.3812.4981.882.5872.3882.0541.1561.1291.69730.7530.4560.7150.5710.4025.003
Overige kosten -0.0880000-0.0650.1240.04700000000000000000000
Bedrijfskosten 8.7859.9989.9297.96910.4979.76211.15711.17221.57412.66622.86616.54215.73123.00418.2121.50318.45813.85115.78213.42610.30711.4913.1235.677.7229.6245.6685.003
Bedrijfsresultaat -8.854-9.998-10.039-7.969-10.497-9.762-11.03-11.172-21.574-12.666-22.649-16.542-15.731-23.004-17.767-21.503-18.458-13.851-15.685-13.426-10.307-11.49-12.877-5.67-7.722-9.624-5.668-5.003
Bedrijfsresultaat ratio 000000000000000000000000-6.963-8.472-6.4160
Totaal overige inkomsten en kosten netto 0.20100.2830.3140.2860.2170.0820.0750.0260.020.030.0350.0380.0420.0470.0480.0510.0670.050.0440.052-0.096-0.090-0.0020-0.004-0.051
Inkomen voor belasting -8.653-9.804-9.756-7.655-10.211-9.545-10.948-11.097-21.548-12.646-22.619-16.507-15.693-22.962-17.72-21.455-18.407-13.784-15.635-13.382-10.255-11.586-12.967-5.67-7.724-9.624-5.672-5.054
Inkomen voor belasting ratio 000000000000000000000000-6.965-8.472-6.4210
Belastingkosten 00.0010.0660.3150.292-0.217-0.082-0.0750.0290.0210.030.0350.0390.0420.0470.0480.0510.0680.0610.0630000000-0.051
Nettowinst -8.653-9.804-9.756-7.655-10.211-9.328-10.866-11.022-21.548-12.646-22.619-16.507-15.693-22.962-17.72-21.455-18.407-13.784-15.635-13.382-10.255-11.586-12.967-5.67-7.724-9.624-5.672-5.054
Nettowinstmarge 000000000000000000000000-6.965-8.472-6.4210
WPA (Winst Per Aandeel) -0.12-0.14-0.16-0.12-0.16-0.15-0.21-0.22-0.43-0.33-0.53-0.43-0.41-0.6-0.45-0.55-0.47-0.35-0.4-0.34-0.26-0.29-0.33-0.23-0.39-0.39-0.23-0.27
Verwaterde WPA -0.12-0.14-0.16-0.12-0.16-0.15-0.21-0.22-0.42-0.32-0.51-0.43-0.41-0.6-0.45-0.54-0.47-0.35-0.4-0.34-0.26-0.29-0.33-0.23-0.39-0.39-0.23-0.27
EBITDA -8.785-9.694-9.929-7.545-10.08-9.413-10.812-10.952-21.4-12.501-22.474-16.361-15.531-22.838-17.584-21.325-18.287-13.674-15.521-13.3-10.219-11.454-12.833-5.635-7.71-9.612-5.66-0.051
EBITDA ratio 000000000000000000000000-6.952-8.461-6.4070